Trulieve Cannabis Corp.
TRLV evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for TRLV—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$1.94B
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Mar 31, 2026.
Run Trulieve Cannabis Corp. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Trulieve Cannabis Corp. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
OCF $56M
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
4
Total value held
$1.0M
| Holder | Shares | Value |
|---|---|---|
| nano cap new millennium growth fund l p | 145,000 | $812K |
| albert d mason inc | 39,203 | $220K |
| hurley capital, llc | 526 | $3K |
| resources management corp /ct/ /adv | 46 | $0 |
Governance
Frequently asked questions
Who is the CEO of Trulieve Cannabis Corp.?
Ms. Kimberly Rivers J.D. is the chief executive officer of Trulieve Cannabis Corp. (TRLV).
Where is Trulieve Cannabis Corp. headquartered?
Trulieve Cannabis Corp. (TRLV) is headquartered in Tallahassee, FL, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.